Cargando…

Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics

We aimed to discover prognostic factors of muscle-invasive bladder cancer (MIBC) and investigate their relationship with immune therapies. Online data of MIBC were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus database (GEO) database. Weighted gene co-expression network an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xianglai, Wang, Yelin, Zhang, Sihong, Zhu, Yanjun, Wang, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558584/ https://www.ncbi.nlm.nih.gov/pubmed/34733102 http://dx.doi.org/10.1177/11769343211049270

Ejemplares similares

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience
por: Gerardi, Marianna A., et al.
Publicado: (2016)

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
por: Del Bene, Gabriella, et al.
Publicado: (2018)

A systematic review and meta-analysis of radical cystectomy in the treatment of muscular invasive bladder cancer (MIBC)
por: Zhao, Juan, et al.
Publicado: (2021)

The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
por: Sun, Jian-Xuan, et al.
Publicado: (2023)

Single dose Tadalafil 5 mg in Muscle Invasive Bladder Cancer (MIBC) patient induce priapism: A case report and literature review
por: Prabharani, Diaswara, et al.
Publicado: (2022)

HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma
por: Xu, Xianglai, et al.
Publicado: (2023)

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses
por: Li, Pan, et al.
Publicado: (2020)

Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study
por: Zhang, Heng, et al.
Publicado: (2020)

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
por: Verghote, Flor, et al.
Publicado: (2021)

Study on the Strengthening Mechanism of a MIBC–PEG Mixed Surfactant on Foam Stability
por: Xu, Mengdi, et al.
Publicado: (2023)

Impact of COVID-19 on Management of MIBC: a Quantitative and Temporal Analysis
por: Kombathula, S.H., et al.
Publicado: (2023)

Beneficial Use of MIBC in Metakaolin-Based Geopolymers to Improve Flowability and Compressive Strength
por: Lee, Sujeong, et al.
Publicado: (2020)

LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis
por: Wang, Yongfeng, et al.
Publicado: (2022)

The prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics
por: Yu, Xin, et al.
Publicado: (2023)

Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer
por: Chen, Liang, et al.
Publicado: (2017)

Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

Explore prognostic biomarker of bladder cancer based on competing endogenous network
por: Li, Faping, et al.
Publicado: (2020)

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database
por: Jin, Kun, et al.
Publicado: (2021)

Bioinformatics analysis of key biomarkers for bladder cancer
por: Liu, Wentao, et al.
Publicado: (2022)

Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
por: Xu, Xianglai, et al.
Publicado: (2023)

Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
por: Xu, Xianglai, et al.
Publicado: (2023)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2017)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

Species Surface Distribution and Surface Tension of Aqueous Solutions of MIBC and NaCl Using Molecular Dynamics Simulations
por: Alvarado, Omar, et al.
Publicado: (2022)

Role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer
por: Singla, Sahil, et al.
Publicado: (2023)

Comment on “The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer”
por: Wang, Dexin, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Exploration of biomarkers in osteoarthritis based on bioinformatics
por: Ye, Tong, et al.
Publicado: (2021)

Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy – protocol of a multicentre, single arm phase 2 trial (SAKK 06/19)
por: Petrausch, Ulf, et al.
Publicado: (2023)

The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
por: Zhang, Jingqi, et al.
Publicado: (2020)

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2016)

PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
por: Wang, Chenyu, et al.
Publicado: (2022)

Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
por: Mo, Qianxing, et al.
Publicado: (2020)

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
por: Murphy, Neal, et al.
Publicado: (2022)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3bqu1addalhgi0iu4dnodc1vm